These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25348610)

  • 1. Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice.
    Keyhani-Nejad F; Irmler M; Isken F; Wirth EK; Beckers J; Birkenfeld AL; Pfeiffer AF
    Diabetologia; 2015 Feb; 58(2):374-83. PubMed ID: 25348610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction.
    Keyhani-Nejad F; Barbosa Yanez RL; Kemper M; Schueler R; Pivovarova-Ramich O; Rudovich N; Pfeiffer AFH
    Peptides; 2020 Mar; 125():170231. PubMed ID: 31870938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
    Thondam SK; Cuthbertson DJ; Wilding JPH
    Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain.
    Maekawa R; Ogata H; Murase M; Harada N; Suzuki K; Joo E; Sankoda A; Iida A; Izumoto T; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Arima H; Hayashi Y; Seino Y
    Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E572-E583. PubMed ID: 29406782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in
    Shimazu-Kuwahara S; Harada N; Yamane S; Joo E; Sankoda A; Kieffer TJ; Inagaki N
    Mol Metab; 2017 Mar; 6(3):288-294. PubMed ID: 28271035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice.
    Isken F; Weickert MO; Tschöp MH; Nogueiras R; Möhlig M; Abdelrahman A; Klaus S; Thorens B; Pfeiffer AF
    Diabetologia; 2009 Oct; 52(10):2159-68. PubMed ID: 19644669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented gastric inhibitory polypeptide and insulin responses to a meal after an increase in carbohydrate (sucrose) intake.
    Mazzaferri EL; Starich GH; St Jeor ST
    J Clin Endocrinol Metab; 1984 Apr; 58(4):640-5. PubMed ID: 6365944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
    Musso G; Gambino R; Pacini G; De Michieli F; Cassader M
    Am J Clin Nutr; 2009 Feb; 89(2):558-67. PubMed ID: 19141695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of palatinose vs sucrose improves hyperglycemia in normal C57BL/6J mice.
    Hwang D; Park HR; Lee SJ; Kim HW; Kim JH; Shin KS
    Nutr Res; 2018 Nov; 59():44-52. PubMed ID: 30442232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice.
    Shimotoyodome A; Fukuoka D; Suzuki J; Fujii Y; Mizuno T; Meguro S; Tokimitsu I; Hase T
    Endocrinology; 2009 May; 150(5):2118-26. PubMed ID: 19179446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes.
    Gault VA; Irwin N; Green BD; McCluskey JT; Greer B; Bailey CJ; Harriott P; O'harte FP; Flatt PR
    Diabetes; 2005 Aug; 54(8):2436-46. PubMed ID: 16046312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic, hormonal and performance effects of isomaltulose ingestion before prolonged aerobic exercise: a double-blind, randomised, cross-over trial.
    Notbohm HL; Feuerbacher JF; Papendorf F; Friese N; Jacobs MW; Predel HG; Zacher J; Bloch W; Schumann M
    J Int Soc Sports Nutr; 2021 May; 18(1):38. PubMed ID: 34001166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
    Irwin N; McClean PL; O'Harte FP; Gault VA; Harriott P; Flatt PR
    Diabetologia; 2007 Jul; 50(7):1532-40. PubMed ID: 17486314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
    Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
    Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
    Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling.
    Zhang Q; Delessa CT; Augustin R; Bakhti M; Colldén G; Drucker DJ; Feuchtinger A; Caceres CG; Grandl G; Harger A; Herzig S; Hofmann S; Holleman CL; Jastroch M; Keipert S; Kleinert M; Knerr PJ; Kulaj K; Legutko B; Lickert H; Liu X; Luippold G; Lutter D; Malogajski E; Medina MT; Mowery SA; Blutke A; Perez-Tilve D; Salinno C; Sehrer L; DiMarchi RD; Tschöp MH; Stemmer K; Finan B; Wolfrum C; Müller TD
    Cell Metab; 2021 Apr; 33(4):833-844.e5. PubMed ID: 33571454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of GIP secretion alleviates age-related obesity and insulin resistance.
    Kanemaru Y; Harada N; Shimazu-Kuwahara S; Yamane S; Ikeguchi E; Murata Y; Kiyobayashi S; Hatoko T; Inagaki N
    J Endocrinol; 2020 Apr; 245(1):13-20. PubMed ID: 31977316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of glucose-dependent insulinotropic polypeptide receptor prevents ovariectomy-induced obesity in mice.
    Isken F; Pfeiffer AF; Nogueiras R; Osterhoff MA; Ristow M; Thorens B; Tschöp MH; Weickert MO
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E350-5. PubMed ID: 18505834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Glycemic Index Metabolic Damage - a Pivotal Role of GIP and GLP-1.
    Pfeiffer AFH; Keyhani-Nejad F
    Trends Endocrinol Metab; 2018 May; 29(5):289-299. PubMed ID: 29602522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
    Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
    J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.